Survival benefits of complete ablation in patients with BCLC stage B hepatocellular carcinoma receiving transarterial chemoembolization and systemic therapy
The role of ablation in BCLC stage B hepatocellular carcinoma (HCC) remains unclear, particularly in the setting of transarterial chemoembolization (TACE) combination with systemic therapy. Our study assessed the impact of ablation on survival and developed a model to identify patients most likely to benefit from...